ERBB2 and breast cancer: Breast cancer is divided into 3 main subtypes based on molecular markers for estrogen (ER) or progesterone (PR) receptors and human epidermal growth factor 2 (ERBB2; formerly HER2), and triple negative (tumors lacking all three standard molecular markers) [3].